title: Development of hypocalcemia with telaprevir-based triple treatment in a case of genotype 1 chronic hepatitis C.
authors.affiliation: Department of Gastroenterology, Istanbul Medeniyet University Faculty of Medicine, Göztepe Training and Research Hospital, Istanbul, Turkey. ebubekirsenates@yahoo.com.
authors.forename: Ebubekir
authors.initials: E
authors.lastname: Şenateş
authors.forename: Yaşar
authors.initials: Y
authors.lastname: Çolak
authors.forename: Atakan
authors.initials: A
authors.lastname: Yeşil
authors.forename: İlyas
authors.initials: İ
authors.lastname: Tuncer
mesh_terms: D000998:Antiviral Agents / Q000009:adverse effects*; D004359:Drug Therapy, Combination / Q000009:adverse effects; D005260:Female; D005838:Genotype; D016174:Hepacivirus / Q000235:genetics; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D006996:Hypocalcemia / Q000139:chemically induced*; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D008875:Middle Aged; D009842:Oligopeptides / Q000009:adverse effects*; D011092:Polyethylene Glycols / Q000009:adverse effects*; D011994:Recombinant Proteins / Q000009:adverse effects
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D009842:Oligopeptides; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C486464:telaprevir; C417083:peginterferon alfa-2b